Loading clinical trials...
Loading clinical trials...
Open, Non-Interventional, Multicentre Trial of Rituximab in Combination With FC for the First-Line Therapy of Patients With Chronic Lymphocytic Leukaemia
Evaluation of safety profile and tolerability of MabThera (rituximab) in combination with chemotherapy (fludarabine and cyclophosphamide) in the treatment of Chronic Lymphocytic Leukemia (CLL).
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Belgrade, Serbia
Kragujevac, Serbia
Novi Sad, Serbia
Start Date
July 1, 2009
Primary Completion Date
December 1, 2011
Completion Date
December 1, 2011
Last Updated
November 2, 2016
22
ACTUAL participants
No intervention
OTHER
Lead Sponsor
Hoffmann-La Roche
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions